Alembic Pharma announced that it has received the final approval from US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) of Vilazodone Hydrochloride Tablets, 10 mg, 20 mg and 40 mg. The approved ANDA is equivalent to the reference listed product, Viibryd Tablets, 10 mg, 20 mg and 40 mg of Allergan Sales Limited.